Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cells

Figure 1

Anti-proliferative properties of LGD1069 in endothelial cells. Panel A showed the results analyzed by MTT assay. Cells were incubated with LGD1069 in the presence of 2 ng/ml VEGF, at different concentrations for 24, 48 and 96h, respectively. The IC50 value for 96h was 16.6 ± 6.7 μM. Panel B is the results of SRB assay. The HUVEC cells were treated with LGD1069 for 96h at different concentrations, and the IC50 value was 21.4 ± 5.9 μM. Vehicle (DMSO) was used as a control in both of the viability assay. Data were expressed as mean ± SD. (n = 3).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us